CHF-6563
- Generic Name
- CHF-6563
CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome
Phase 2
Terminated
- Conditions
- Neonatal Opioid Withdrawal Syndrome
- Interventions
- First Posted Date
- 2019-09-26
- Last Posted Date
- 2023-08-03
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 7
- Registration Number
- NCT04104646
- Locations
- 🇺🇸
Clinical site 015, Las Vegas, Nevada, United States
🇺🇸Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath